SpyGlass Pharma Stock (NASDAQ:SGP)
Previous Close
$21.18
52W Range
$17.06 - $32.44
50D Avg
$21.40
200D Avg
$23.66
Market Cap
$723.83M
Avg Vol (3M)
$96.03K
Beta
-0.34
Div Yield
-
SGP Company Profile
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.